Jazz Pharmaceuticals Plc (JAZZ)

136.62
NASDAQ : Health Technology
Prev Close 138.23
Day Low/High 133.25 / 138.50
52 Wk Low/High 113.52 / 181.46
Avg Volume 477.90K
Exchange NASDAQ
Shares Outstanding 56.64M
Market Cap 7.83B
EPS 7.50
P/E Ratio 17.24
Div & Yield N.A. (N.A)

Latest News

Friday Excitement

Trader's Daily Notebook: For a Decline, It Sure Was Smooth

Trader's Daily Notebook: For a Decline, It Sure Was Smooth

But we could see more volatility in the market.

Biotech M&A Waking Up After Long Nap

Biotech M&A Waking Up After Long Nap

The uptick in the small- and mid-cap space bodes well for future capital appreciation.

Mylan Deal the Rx for Drug Stocks

Even the second-tier biotechs are taking off.

Nasdaq 5000 Is Meaningless

Stay focused on price and remember that the market's riding a trend.

A Bit Late to Two Parties

But not too late to stop chasing entries.

Fitz Bits: GoPro Is Killing the Bears

Fitz Bits: GoPro Is Killing the Bears

I think it's going to hit $100 in the next few months.

The Trader Daily

The iShares Transportation Average (IYT) is one to watch.

The Trader Daily

Don't batten down the hatches yet.

Get Used to the New Market Reality

Algos think faster and react faster than humans can.

Wait for Your Cue in Jazz Pharma

The technicals look good, but don't dive in just yet.

This Froth Has to Be Reined In

The public market is currently divorced from the dazzling IPOs -- and that's always a bad sign.

A Trio of Breakouts

A Trio of Breakouts

Jazz Pharma, Qihoo and Rite-Aid are all on fire today.

Biotech Remains on Fast Track

Even after a run, some stocks still offer growth.

Going Solar

The group's been leading and it should continue to perform in 2014.

The Action Is High

But trust in this market is low.

Music to My Ears

Here's why I like a lower opening.

Meet the New 'Four Horsemen'

Catch them if you can.

Jazz increases price target at UBS

Rules of the Game: Investment Philosophy

Think of how investments will help you in the future.

Jazz numbers raised at UBS